Hurdles to clinical translation of human induced pluripotent stem cells
作者： Evgenios Neofytou , Connor Galen O’Brien , Larry A. Couture , Joseph C. Wu
DOI: 10.1172/JCI80575
关键词:
摘要: … The most significant posttransplantation safety concern is the … cell clinical products undergo safety/toxicity studies before … In addition, cell products must be tested rigorously for acute …
sci-hub.st 参考文章(56)
Karine Toupet, Marie Maumus, Julie-Anne Peyrafitte, Philippe Bourin, Peter L. E. M. van Lent, Rosanna Ferreira, Béatrice Orsetti, Nelly Pirot, Louis Casteilla, Christian Jorgensen, Danièle Noël, Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID mice. Arthritis & Rheumatism. ,vol. 65, pp. 1786- 1794 ,(2013) , 10.1002/ART.37960
Christopher A. Bravery, Do human leukocyte antigen-typed cellular therapeutics based on induced pluripotent stem cells make commercial sense? Stem Cells and Development. ,vol. 24, pp. 1- 10 ,(2015) , 10.1089/SCD.2014.0136
Laureen Jacquet, Emma Stephenson, Robert Collins, Heema Patel, Jane Trussler, Roaa Al‐Bedaery, Pamela Renwick, Caroline Ogilvie, Robert Vaughan, Dusko Ilic, Strategy for the creation of clinical grade hESC line banks that HLA‐match a target population Embo Molecular Medicine. ,vol. 5, pp. 10- 17 ,(2013) , 10.1002/EMMM.201201973
Pierre-Antoine Gourraud, Leena Gilson, Mathilde Girard, Marc Peschanski, The Role of Human Leukocyte Antigen Matching in the Development of Multiethnic “Haplobank” of Induced Pluripotent Stem Cell Lines Stem Cells. ,vol. 30, pp. 180- 186 ,(2012) , 10.1002/STEM.772
Melissa K Carpenter, Joyce Frey-Vasconcells, Mahendra S Rao, Developing safe therapies from human pluripotent stem cells. Nature Biotechnology. ,vol. 27, pp. 606- 613 ,(2009) , 10.1038/NBT0709-606
Uri Ben-David, Qing-Fen Gan, Tamar Golan-Lev, Payal Arora, Ofra Yanuka, Yifat S. Oren, Alicia Leikin-Frenkel, Martin Graf, Ralph Garippa, Markus Boehringer, Gianni Gromo, Nissim Benvenisty, Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell. ,vol. 12, pp. 167- 179 ,(2013) , 10.1016/J.STEM.2012.11.015
Andrew S Lee, Chad Tang, Mahendra S Rao, Irving L Weissman, Joseph C Wu, Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies Nature Medicine. ,vol. 19, pp. 998- 1004 ,(2013) , 10.1038/NM.3267
Nan Cao, He Liang, Jijun Huang, Jia Wang, Yixiong Chen, Zhongyan Chen, Huang-Tian Yang, Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions Cell Research. ,vol. 23, pp. 1119- 1132 ,(2013) , 10.1038/CR.2013.102
Norio Nakatsuji, Fumiaki Nakajima, Katsushi Tokunaga, HLA-haplotype banking and iPS cells. Nature Biotechnology. ,vol. 26, pp. 739- 740 ,(2008) , 10.1038/NBT0708-739
Tobias Deuse, Dong Wang, Mandy Stubbendorff, Ryo Itagaki, Antje Grabosch, Laura C. Greaves, Malik Alawi, Anne Grünewald, Xiaomeng Hu, Xiaoqin Hua, Joachim Velden, Hermann Reichenspurner, Robert C. Robbins, Rudolf Jaenisch, Irving L. Weissman, Sonja Schrepfer, SCNT-Derived ESCs with Mismatched Mitochondria Trigger an Immune Response in Allogeneic Hosts Cell Stem Cell. ,vol. 16, pp. 33- 38 ,(2015) , 10.1016/J.STEM.2014.11.003